Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia

פרסום מחקרי: פרסום בכתב עת › מזכר › ביקורת עמיתים

21 ציטוטים ‏(Scopus)

גישה למסמך

@article{7f2827dedb494f50b638370f8f36c2dc,

title = "Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia",

author = "Tamar Tadmor and Ohad Benjamini and Andrei Braester and Galia Rahav and Lior Rokach",

year = "2021",

month = sep,

doi = "10.1038/s41375-021-01380-5",

language = "אנגלית",

volume = "35",

pages = "2727--2730",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "9",

}

TY - JOUR

T1 - Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia

AU - Tadmor, Tamar

AU - Benjamini, Ohad

AU - Braester, Andrei

AU - Rahav, Galia

AU - Rokach, Lior

PY - 2021/9

Y1 - 2021/9

UR - https://www.scopus.com/pages/publications/85112139438

U2 - 10.1038/s41375-021-01380-5

DO - 10.1038/s41375-021-01380-5

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 34376803

AN - SCOPUS:85112139438

SN - 0887-6924

VL - 35

SP - 2727

EP - 2730

JO - Leukemia

JF - Leukemia

IS - 9

ER -